| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.265.10.1287 |
| P698 | PubMed publication ID | 1995976 |
| P50 | author | William J. Blot | Q91272971 |
| P2093 | author name string | J F Fraumeni | |
| S S Devesa | |||
| R W Kneller | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 1287-1289 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Rising incidence of adenocarcinoma of the esophagus and gastric cardia | |
| P478 | volume | 265 |
| Q52707757 | A New Gastric Cancer Among Us. |
| Q35993930 | A case-control study of cancers of the gastric cardia in Italy. |
| Q36641791 | A case-control study of oesophageal adenocarcinoma in women: a preventable disease |
| Q35006537 | A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism |
| Q72606287 | A current view of gastric cancer in the US |
| Q36383409 | A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma |
| Q42370438 | A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma |
| Q73695320 | A new approach for the surgical treatment of Barrett's esophagus |
| Q78206482 | A new approach to the palliation of advanced proximal gastric cancer |
| Q73554965 | A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens |
| Q36753025 | A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus |
| Q36524591 | A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. |
| Q53627560 | A novel external esophageal perfusion model for reflux esophageal injury. |
| Q28485310 | A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers |
| Q28362828 | A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy |
| Q37697608 | A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction |
| Q34307924 | A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers |
| Q33366008 | A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients |
| Q37225713 | A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma |
| Q35579697 | A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection. |
| Q46053830 | A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA. |
| Q50524924 | A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation. |
| Q84937127 | A preoperative nomogram to predict the risk of perioperative mortality following gastric resections for malignancy |
| Q36597089 | A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma |
| Q33841542 | A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer |
| Q80059918 | A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents |
| Q43244148 | A single center's 30 years' experience of esophageal adenocarcinoma |
| Q34371096 | A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma |
| Q35953876 | Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms |
| Q36884198 | Ablative therapies for the columnar-lined esophagus |
| Q38762315 | Acetylsalicylic Acid Exhibits Antitumor Effects in Esophageal Adenocarcinoma Cells In Vitro and In Vivo |
| Q40512079 | Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors |
| Q38273489 | Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma. |
| Q35790574 | Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? |
| Q37770081 | Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies |
| Q49212612 | Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery |
| Q50602557 | Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. |
| Q45178209 | Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease |
| Q46947615 | Adenocarcinoma of the esophagus in the young |
| Q43650782 | Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study |
| Q33944994 | Adenocarcinoma of the stomach: a review |
| Q41748055 | Adenocarcinoma of the upper esophagus arising in cervical ectopic gastric mucosa: rare evidence of malignant potential of so-called "inlet patch". |
| Q72680681 | Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma |
| Q37037845 | Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China |
| Q37258937 | Adjuvant and neoadjuvant therapy of gastric cancer: a comparison of three pivotal studies |
| Q37076527 | Adjuvant and preoperative therapy for localized gastric cancer. |
| Q28088619 | Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review |
| Q41830462 | Advanced gastric cancer: a disease of diverse clinical biology. |
| Q34057520 | Advances in diagnostic and therapeutic endoscopy |
| Q34833699 | Alcohol as a cause of cancer |
| Q33392419 | Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men |
| Q37176043 | Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus |
| Q36622783 | Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma |
| Q41931838 | Allelotype analysis of adenocarcinoma of the gastric cardia |
| Q36506326 | Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China |
| Q24550868 | Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas |
| Q72534417 | Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site |
| Q40468473 | An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. |
| Q47900061 | Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis |
| Q73512661 | Are metal stents effective for palliation of malignant dysphagia and fistulas? |
| Q32060710 | Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up |
| Q77083316 | Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population |
| Q79760906 | Assessment of clinical impact of endoscopic ultrasound on esophageal cancer |
| Q87193521 | Association between gastric cardia adenocarcinoma risk and alcohol flushing response, but not alcohol consumption |
| Q46476447 | Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study |
| Q35726219 | Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan. |
| Q35942044 | Association of dietary fat intakes with risk of esophageal and gastric cancer in the NIH-AARP diet and health study |
| Q33800881 | Atrial fibrillation after esophagectomy: an indicator of postoperative morbidity |
| Q37591969 | Barrett esophagus in Asia: same disease with different pattern |
| Q73826468 | Barrett's esophagus |
| Q40406954 | Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem |
| Q36474658 | Barrett's esophagus and its correlation with gastroesophageal reflux in Chinese. |
| Q34408906 | Barrett's esophagus and the increasing role of endoluminal therapy |
| Q37579978 | Barrett's esophagus on repeat endoscopy: should we look more than once? |
| Q36542774 | Barrett's esophagus--Who, how, how often and what to do with dysplasia? |
| Q33850208 | Barrett's esophagus. Reducing the risk of progression to adenocarcinoma |
| Q40915871 | Barrett's esophagus. The significance of p53 in clinical practice |
| Q35113474 | Barrett's esophagus: an update |
| Q31058387 | Barrett's esophagus: best of Digestive Disease Week 2003. |
| Q34755941 | Barrett's esophagus: clinical characteristics |
| Q35630825 | Barrett's esophagus: histopathologic definitions and diagnostic criteria |
| Q34353530 | Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management |
| Q44846105 | Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms |
| Q24791935 | Barrett's oesophagus and adenocarcinoma |
| Q34458639 | Barrett's oesophagus: a review of costs of the illness |
| Q35091942 | Barrett's oesophagus: optimal strategies for prevention and treatment |
| Q39614242 | Bile acids but not acidic acids induce Barrett's esophagus |
| Q41601270 | Biomarkers for malignancy in the columnar-lined esophagus |
| Q33425118 | Body mass index and Barrett's oesophagus in women |
| Q34576888 | Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study |
| Q36232937 | CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis |
| Q25257847 | CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate |
| Q84018600 | Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction? |
| Q35665116 | Cancer of the esophagus: histopathological sub-types in northern Uganda |
| Q51734991 | Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. |
| Q41104900 | Cancer of the oesophagus |
| Q36616002 | Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial |
| Q37353860 | Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States |
| Q38548565 | Carcinogenesis of Barrett's esophagus: a review of the clinical literature |
| Q34666896 | Carcinoma of esophagus: radiologic diagnosis and staging |
| Q36529125 | Carcinoma of the gastroesophageal junction in Chinese patients |
| Q33919260 | Cell cycle regulation in patients with intestinal metaplasia at the gastro-oesophageal junction |
| Q36081163 | Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence |
| Q36372310 | Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China |
| Q45885355 | Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. |
| Q33901236 | Changing pattern of esophageal cancer incidence in New Mexico: a 30-year evaluation |
| Q36777065 | Changing times. Annual oration: Royal Victoria Hospital, Belfast, October 2001. |
| Q77448781 | Characteristics and clinical outcome of proximal-third gastric cancer |
| Q83764553 | Characteristics of gastric cancer with esophageal invasion and aspects of surgical treatment |
| Q36496675 | Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma |
| Q83229868 | Characterization of the gastric cardia in volunteers from the general population. Type of mucosa, Helicobacter pylori infection, inflammation, mucosal proliferative activity, p53 and p21 expression, and relations to gastritis |
| Q73502951 | Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus |
| Q41533845 | Chemotherapy in oesophageal cancer |
| Q30837765 | Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence |
| Q35363348 | Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer |
| Q54646160 | Claudin expression in Barrett's esophagus and adenocarcinoma. |
| Q33422612 | Clinical experience with pantoprazole in gastroesophageal reflux disease |
| Q33922534 | Clinical impact of tumour biology in the management of gastroesophageal cancer |
| Q26862365 | Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach |
| Q83006219 | Clinical outcomes of using a conservative approach of late esophageal stent placement in palliation of malignant dysphagia |
| Q96231788 | Clinical profile of patients presenting with dysphagia - an experience from a tertiary care center in North India |
| Q72203493 | Clinicopathologic features of gastric cancer infiltrating the lower esophagus |
| Q91939098 | Clinicopathological Characteristics and Prognosis of Proximal and Distal Gastric Cancer during 1997-2017 in China National Cancer Center |
| Q87396258 | Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study |
| Q36491994 | Clinicopathological analysis of patients with gastric cancer in 1200 cases |
| Q37411124 | Clinicopathological features and prognosis of patients <45 years old with esophageal adenocarcinoma comparing to other age groups |
| Q35017035 | Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue |
| Q30433528 | Clustering of molecular alterations in gastroesophageal carcinomas |
| Q70864731 | Combined choriocarcinoma, hepatoid adenocarcinoma, small cell carcinoma and tubular adenocarcinoma in the oesophagus |
| Q34603498 | Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans |
| Q72680677 | Comparative studies of cardia carcinoma and infracardial gastric carcinoma |
| Q35596193 | Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus |
| Q34269220 | Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma |
| Q36294859 | Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia |
| Q83816487 | Comparison of results of surgery in the upper third and more distal stomach |
| Q52901579 | Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett’s esophagus |
| Q87398892 | Comparison of the clinicopathological characteristics and the survival outcomes between the Siewert type II/III adenocarcinomas |
| Q36194016 | Comparisons Between Different Procedures of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy |
| Q36083593 | Comparisons of Gastric Cancer Treatments: East vs. West |
| Q35357755 | Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. |
| Q53310436 | Concomitant Hodgkin's lymphoma and gastric adenocarcinoma: a rare coincidence. |
| Q37153044 | Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus |
| Q34734891 | Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model |
| Q51511597 | Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas. |
| Q43040594 | Correlation of oesophageal acid exposure with Barrett's oesophagus length |
| Q34410091 | Cost effectiveness of detecting Barrett's cancer |
| Q37076597 | Crossroads in the combined-modality management of gastroesophageal junction carcinomas. |
| Q35942251 | Current management of gastric cancer |
| Q34251273 | Current status of ablative therapies in esophageal disorders |
| Q33788585 | Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma |
| Q73823167 | Cyclooxygenase-2 expression in Barrett's esophagus |
| Q28364165 | Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology |
| Q73931108 | Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens |
| Q77424917 | Cytological screening for Barrett's esophagus using a prototype flexible mesh catheter |
| Q34039344 | Cytotoxic Effects of Newly Synthesized Palladium(II) Complexes of Diethyldithiocarbamate on Gastrointestinal Cancer Cell Lines. |
| Q33541029 | Declining death rates reflect progress against cancer |
| Q35977801 | Declining incidence is greater for esophageal than gastric cancer in Shanghai, People's Republic of China |
| Q48525157 | Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy |
| Q47107946 | Demographic and clinical factors associated with suicide in gastric cancer in the United States |
| Q44219252 | Descriptive epidemiology of gastric adenocarcinoma in the state of Texas by ethnicity: Hispanic versus White non-Hispanic |
| Q34463281 | Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques |
| Q40940859 | Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). |
| Q33289539 | Developments in esophageal surgery for adenocarcinoma: a comparison of two decades |
| Q36791631 | Diagnosis and treatment of esophageal neoplasms |
| Q36626117 | Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates |
| Q33554117 | Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis |
| Q37591501 | Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer |
| Q74741451 | Diet, nutrients, and gastrointestinal cancer |
| Q40116106 | Dietary Flavonoid Intake Reduces the Risk of Head and Neck but Not Esophageal or Gastric Cancer in US Men and Women. |
| Q37327500 | Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus |
| Q34711005 | Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus |
| Q36038972 | Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett's esophagus risk: a systematic review and meta-analysis |
| Q42032167 | Dietary patterns and the risk of Barrett's esophagus |
| Q90104653 | Dietary polyunsaturated fat intake in relation to head and neck, esophageal, and gastric cancer incidence in the NIH-AARP Diet and Health Study |
| Q36341684 | Differences in gastric cancer survival between the U.S. and China |
| Q35691577 | Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori |
| Q36474577 | Differences in proximal (cardia) versus distal (antral) gastric carcinogenesis via the retinoblastoma pathway. |
| Q36609914 | Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach |
| Q35579081 | Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease? |
| Q90061844 | Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal Adenocarcinoma |
| Q36618278 | Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas |
| Q58204685 | Disparities in the Classification of Esophageal and Cardia Adenocarcinomas and Their Influence on Reported Incidence Rates |
| Q37123537 | Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? |
| Q92384157 | Dorsal Track Control (DTC): A Modified Surgical Technique for Atraumatic Handling of the Distal Esophagus in Esophagojejunostomy |
| Q52665375 | Dosimetric Analysis of Unflattened (FFFB) and Flattened (FB) Photon Beam Energy for Gastric Cancers Using IMRT and VMAT-a Comparative Study. |
| Q44324357 | Duodenal reflux produces hyperproliferative epithelial esophagitis--a possible precursor to esophageal adenocarcinoma in the rat. |
| Q77643885 | Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen |
| Q71835007 | Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade |
| Q39773312 | Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model |
| Q39595493 | Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma |
| Q46084994 | Early gastric cancer shows different associations with adipose tissue volume depending on histological type |
| Q36180453 | Effect of body mass index on adenocarcinoma of gastric cardia |
| Q50188597 | Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms |
| Q46072702 | Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model |
| Q44979609 | Effect of proton pump inhibitor therapy on inflammatory changes in the gastric cardia (carditis). |
| Q84764178 | Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus |
| Q30883191 | Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis |
| Q37396047 | Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus |
| Q36659456 | Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist. |
| Q30922535 | Endoscopic ablation of Barrett's esophagus |
| Q31156678 | Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. |
| Q51754022 | Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. |
| Q34756224 | Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits |
| Q35165873 | Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience |
| Q33951485 | Endoscopic practice at the start of the new millennium. |
| Q54111493 | Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. |
| Q30493713 | Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction. |
| Q28388848 | Environmental causes of esophageal cancer |
| Q36117678 | Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? |
| Q35594373 | Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA |
| Q36079424 | Epidemiological features of gastric and oesophageal cancers in Slovakia |
| Q27027061 | Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease |
| Q60956958 | Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea |
| Q41601235 | Epidemiology of columnar-lined esophagus and adenocarcinoma |
| Q33788193 | Epidemiology of gastric cancer |
| Q37286328 | Epidemiology of gastric cancer in the gangetic areas of west bengal |
| Q33859882 | Epidemiology of gastric cancer: experience of a Moroccan hospital |
| Q34588743 | Epidemiology of gastroesophageal reflux disease in Asia: a systematic review |
| Q34225787 | Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases |
| Q39580540 | Epstein-Barr virus-associated gastric carcinoma in Japanese Brazilians and non-Japanese Brazilians in São Paulo |
| Q34344181 | Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China |
| Q46970527 | Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. |
| Q47879656 | Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. |
| Q37235137 | Esophageal stem cells--a review of their identification and characterization |
| Q91588976 | Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan |
| Q41183320 | Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer |
| Q27014119 | Ethnic differences in gastric cancer genetic susceptibility: allele flips of interleukin gene |
| Q82741874 | Etiological difference between ultrashort- and short-segment Barrett's esophagus |
| Q28077495 | Etiology and Prevention of Esophageal Cancer |
| Q64912104 | Evaluation of Gastric Carcinomas Histological Patterns in Relation to Tumors Aggressiveness Parameters. |
| Q37504866 | Evaluation of internal target volume in patients undergoing image-guided intensity modulated adjuvant radiation for gastric cancers |
| Q33564217 | Evaluation of routine biopsies in endoscopic screening for esophagogastric junction cancer. |
| Q40614622 | Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy. |
| Q37141674 | Evolution of preoperative and postoperative therapies in the management of localized gastroesophageal cancers |
| Q43977434 | Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre |
| Q77947741 | Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus |
| Q33605428 | Exercise and the Prevention of Oesophageal Cancer (EPOC) study protocol: a randomized controlled trial of exercise versus stretching in males with Barrett's oesophagus |
| Q47877307 | Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus |
| Q74082558 | Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma |
| Q37241051 | Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target? |
| Q42238036 | FDG PET imaging in the staging and management of gastric cancer |
| Q34729169 | FHIT gene therapy prevents tumor development in Fhit-deficient mice. |
| Q64881347 | Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model |
| Q73682764 | Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy |
| Q34780677 | Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults |
| Q34676749 | Fat transforms ascorbic acid from inhibiting to promoting acid-catalysed N-nitrosation |
| Q60934244 | Feasibility of laparoscopic total gastrectomy in overweight patients: Implications of less impact of overweight on laparoscopic versus open approach |
| Q39301768 | Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. |
| Q39712885 | Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization |
| Q34433836 | Food group intake and risk of subtypes of esophageal and gastric cancer |
| Q39101716 | Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression |
| Q35567628 | From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma |
| Q43965829 | Gallstones increase the prevalence of Barrett's esophagus |
| Q77947710 | Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux |
| Q35067625 | Gastric cancer epidemiology and risk factors |
| Q40895598 | Gastric cancer in the European Union (1968-1992): mortality trends and cohort effect |
| Q45059131 | Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group |
| Q37723251 | Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India |
| Q34642023 | Gastric cancer: Classification, histology and application of molecular pathology |
| Q35206807 | Gastric cancer: advances in adjuvant and adjunct therapy |
| Q34194651 | Gastric cancer: an infectious disease |
| Q35739065 | Gastric carcinoma |
| Q35821499 | Gastric carcinomas localized to the cardia |
| Q53207850 | Gastric cardia adenocarcinoma microRNA profiling in Chinese patients. |
| Q84854373 | Gastric cardia cancer: how much is it from fat? |
| Q42737661 | Gastric carditis: Is it a histological response to high concentrations of luminal nitric oxide? |
| Q71545808 | Gastric juice protects against the development of esophageal adenocarcinoma in the rat |
| Q78541496 | Gastric neoplasia |
| Q92412039 | Gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5-CD44+ cells |
| Q43155706 | Gastroesophageal cancer: understanding the disease process and advancing therapy |
| Q31073722 | Gastroesophageal junction adenocarcinoma |
| Q41686367 | Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux |
| Q81602401 | Gastroesophageal reflux disease: clinical features |
| Q35904485 | Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach. |
| Q36109030 | Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma |
| Q74133447 | Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities |
| Q34634735 | Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction |
| Q80101940 | Giant adenoma arising in the lower esophagus with adenocarcinoma |
| Q35977027 | Glutathione and glutathione S-transferases in Barrett's epithelium |
| Q44563226 | H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer |
| Q90483976 | Helicobacter pylori Is Associated With Precancerous and Cancerous Lesions of the Gastric Cardia Mucosa: Results of a Large Population-Based Study in China |
| Q33790164 | Helicobacter pylori and gastric diseases |
| Q73727594 | Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus |
| Q77694133 | Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa |
| Q35050947 | Helicobacter pylori: resurrection of the cancer link |
| Q24797272 | Hereditary risk factors for the development of gastric cancer in younger patients |
| Q36985694 | Hiatal Hernia as a Total Gastrectomy Complication |
| Q35596764 | High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran |
| Q34493151 | High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population. |
| Q36190319 | Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China |
| Q36172200 | Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases? |
| Q54784290 | ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. |
| Q47561735 | Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus |
| Q37285336 | Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography |
| Q55000257 | Immunohistochemical localization of glutathione S-transferase alpha and pi in human esophageal squamous epithelium, Barrett's epithelium and carcinoma. |
| Q35351828 | Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma |
| Q47143606 | Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer. |
| Q72545552 | Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus |
| Q35127216 | Improving endoscopic resolution and sampling: fluorescence techniques |
| Q37136571 | Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. |
| Q31044821 | Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study |
| Q36841557 | Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. |
| Q73351351 | Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms |
| Q35598185 | Increasing incidence of Barrett's oesophagus in the general population |
| Q37138358 | Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002 |
| Q59403613 | Incurable Esophageal Cancer: Patterns of Tumor Spread and Therapeutic Consequences |
| Q36248167 | Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats. |
| Q44271594 | Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection |
| Q46034146 | Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. |
| Q35357359 | Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux disease: a prospective study |
| Q34393702 | Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma |
| Q36397737 | Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China |
| Q41189177 | Inter-endoscopist agreement in diagnosis of Barrett's oesophagus |
| Q35351319 | Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? |
| Q35841290 | Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy |
| Q42056462 | Intrathoracic esophagojejunostomy using OrVil™ for gastric adenocarcinoma involving the esophagus |
| Q36246281 | Intrathoracic leaks following esophagectomy are no longer associated with increased mortality |
| Q35365038 | Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects |
| Q43708315 | Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants |
| Q33349888 | Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial |
| Q32167200 | Is Barrett's esophagus the precursor of most adenocarcinomas of the esophagus and cardia? A biochemical study |
| Q58204642 | Is Esophageal Adenocarcinoma Occurring Late After Antireflux Surgery Due to Persistent Postoperative Reflux? |
| Q79717924 | Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center |
| Q47603176 | Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan |
| Q40413885 | Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma |
| Q53349658 | Laparoscopic mediastinal dissection via an open left diaphragm approach for advanced Siewert type II adenocarcinoma. |
| Q83395210 | Laparoscopic-assisted esophagectomy for adenocarcinoma of the esophagus |
| Q84866096 | Laparoscopy-assisted proximal gastrectomy with sentinel node mapping for early gastric cancer |
| Q37101225 | Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas |
| Q74080617 | Localization of small esophageal cancers for radiation planning using endoscopic contrast injection: report on a series of eight cases |
| Q38619024 | Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States |
| Q44013636 | Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study |
| Q57521919 | Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer |
| Q45374967 | Long-term outcomes of extended proximal gastrectomy for oesophagogastric junctional tumours. |
| Q54951853 | Low glutathione and glutathione S-transferase levels in Barrett's esophagus as compared to normal esophageal epithelium. |
| Q52021883 | Lower esophagus in dyspeptic Iranian patients: a prospective study. |
| Q36949256 | MET expression and amplification in patients with localized gastric cancer |
| Q33446479 | Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan |
| Q35595358 | Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus |
| Q37609156 | Managing Barrett's esophagus with radiofrequency ablation |
| Q37181422 | Measuring patient-reported outcomes in advanced gastric cancer |
| Q37591708 | Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma |
| Q36803865 | Metabolic syndrome and gastrointestinal diseases |
| Q49195031 | Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjects |
| Q37988359 | MicroRNA and its roles in esophageal cancer. |
| Q37350288 | MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma |
| Q38481127 | Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma |
| Q34463544 | Minimally invasive approach to esophagectomy |
| Q88119105 | Minimally invasive surgery for gastric cancer in USA: current status and future perspectives |
| Q36579704 | Modular video endoscopy for in vivo cross-polarized and vital-dye fluorescence imaging of Barrett's-associated neoplasia |
| Q30500375 | Molecular classification of gastric cancer: a new paradigm |
| Q35842219 | Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions |
| Q33611018 | Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus |
| Q38074157 | Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? |
| Q41601237 | Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma |
| Q40243711 | Mortality predictions for esophageal, stomach, and pancreatic cancer, Ireland, up to 2015. |
| Q33750142 | Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade |
| Q34755986 | Multifocal atrophic gastritis and gastric carcinoma |
| Q40527903 | Multimodality treatment of cancer arising from Barrett's epithelium |
| Q35010373 | Mutations of p53 gene exons 4-8 in human esophageal cancer |
| Q40577988 | NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy |
| Q37391995 | Narrow band imaging in gastroesophageal reflux disease and Barrett's esophagus |
| Q35029201 | Natural history of nonerosive reflux disease. Is all gastroesophageal reflux disease the same? What is the evidence? |
| Q60922961 | Neoadjuvant Chemoradiation Treatment for Resectable Esophago-Gastric Cancer: A Systematic Review and Meta-Analysis |
| Q43981502 | Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer |
| Q24797571 | Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis |
| Q26746147 | Neoadjuvant therapy for gastroesophageal adenocarcinoma |
| Q36993475 | Neoadjuvant treatment for gastric cancer |
| Q42580522 | New approaches to treating oesophageal cancer |
| Q36617794 | New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology |
| Q35355549 | No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden |
| Q35735412 | Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction |
| Q24530094 | Norman Barrett, "doyen of esophageal surgery" |
| Q35923585 | Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma |
| Q41146544 | Nutrition and esophageal cancer. |
| Q42672835 | Occupational mortality from squamous cell carcinoma of the esophagus in the United States during 1991-1996. |
| Q38816897 | Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? |
| Q36080328 | Oesophageal and gastric cancer in Scotland 1960-90. |
| Q37330745 | Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 |
| Q38072285 | Oesophageal cancer--an overview |
| Q40481566 | Oesophageal cancer: On the threshold of hope |
| Q47626643 | Oesophageal cancer: hope for the future? |
| Q73074077 | Oesophageal intestinal metaplasia |
| Q40562951 | Oesophageal xanthalasma with Barrett's Oesophagus and Menetrier's Disease |
| Q43005625 | On the existence and location of cardiac mucosa: an autopsy study in embryos, fetuses, and infants |
| Q35352354 | Opposing time trends of peptic ulcer and reflux disease |
| Q37244793 | Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus |
| Q34469533 | Optical molecular imaging for detection of Barrett's-associated neoplasia |
| Q50718077 | Optimal surgical management for esophagogastric junction carcinoma. |
| Q73931220 | Or is it just a little relaxation? |
| Q33682021 | Outcome of oesophagogastric carcinoma in young patients |
| Q37076550 | Outcomes after surgery for esophageal cancer |
| Q35560014 | Pathological Basis of Gastroesophageal Reflux Disease |
| Q53294313 | Pathology and pathobiology of the oesophageal carcinoma |
| Q36066128 | Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival |
| Q35357928 | Patterns of gastritis in patients with gastro-oesophageal reflux disease |
| Q45875146 | Perspectives of surgery and multimodality treatment in gastric carcinoma |
| Q88079686 | Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma |
| Q33601705 | Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis |
| Q36498930 | Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296). |
| Q43988072 | Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus |
| Q32100250 | Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid |
| Q30758563 | Photodynamic therapy: a review |
| Q33451033 | Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study |
| Q34168546 | Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population |
| Q33691632 | Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases |
| Q31874684 | Postprandial cell proliferation in the esophageal epithelium of rats |
| Q40527919 | Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy |
| Q51559882 | Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis. |
| Q34011842 | Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging |
| Q64090145 | Predictors of dysplastic and neoplastic progression of Barrett’s esophagus |
| Q35017032 | Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables |
| Q24187910 | Preoperative chemotherapy for resectable thoracic esophageal cancer |
| Q77998896 | Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus |
| Q81110253 | Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia |
| Q82712932 | Presentation and prognosis of esophageal adenocarcinoma in patients below age 50 |
| Q34408264 | Preservation of the spleen improves survival after radical surgery for gastric cancer |
| Q35291990 | Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma |
| Q46651328 | Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender |
| Q53495209 | Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. |
| Q43658076 | Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". |
| Q34059892 | Prevalence of metaplasia at the gastro-oesophageal junction |
| Q43658081 | Prevalence of short-segment Barrett's epithelium |
| Q30976366 | Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation |
| Q35151103 | Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China |
| Q35028384 | Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer |
| Q33702570 | Probing the link between oestrogen receptors and oesophageal cancer. |
| Q72063766 | Problem of proximal third gastric carcinoma |
| Q81287622 | Prognosis of upper-third gastric carcinoma patients with invasion of the lower esophagus |
| Q64943593 | Prognostic Impact of Extended Lymph Node Dissection versus Limited Lymph Node Dissection on pN0 Proximal Advanced Gastric Cancer: a Propensity Score Matching Analysis. |
| Q90654424 | Prognostic analysis and liver metastases relevant factors after gastric and hepatic surgical treatment in gastric cancer patients with metachronous liver metastases: a population-based study |
| Q54393227 | Prognostic factors of resected adenocarcinoma of the esophagus. |
| Q52958021 | Progression or regression of Barrett's esophagus--is it all in the eye of the beholder? |
| Q53424556 | Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. |
| Q35364856 | Prolonged measurement of lower oesophageal sphincter function in patients with intestinal metaplasia at the oesophagogastric junction |
| Q73161994 | Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus |
| Q34949732 | Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers |
| Q34462618 | Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms |
| Q33302217 | Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection |
| Q42272015 | Proton pump inhibitors for Barrett's oesophagus |
| Q77379114 | Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus |
| Q51314222 | Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study. |
| Q40666604 | Proximal gastrectomy with exclusion of no. 3b lesser curvature lymph node dissection could be indicated for patients with advanced upper-third gastric cancer. |
| Q41538806 | Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach |
| Q57199852 | Psychosocial working conditions and the risk of esophageal and gastric cardia cancers |
| Q35581378 | Quantitative evaluation of in vivo vital-dye fluorescence endoscopic imaging for the detection of Barrett's-associated neoplasia |
| Q37163647 | Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. |
| Q34479911 | Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy. |
| Q36616011 | Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer |
| Q34974194 | Ratio of metastatic to examined lymph nodes, a helpful staging system and independent prognostic factor of esophagogastric junction cancer |
| Q38352330 | Readmission and risk factors for readmission following esophagectomy for esophageal cancer |
| Q46191291 | Rebamipide inhibits gastric cancer cell growth |
| Q64912862 | Recent advances in the management of gastric adenocarcinoma patients. |
| Q34785283 | Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells |
| Q33617795 | Relation between gastric cancer and previous peptic ulcer disease |
| Q73356236 | Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study |
| Q36474125 | Relationship of gastric Helicobacter pylori infection to Barrett's esophagus and gastro-esophageal reflux disease in Chinese |
| Q35358348 | Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia |
| Q36117210 | Reproductive factors and risk of oesophageal cancer, a population-based nested case-control study in Sweden |
| Q35073657 | Residual embryonic cells as precursors of a Barrett's-like metaplasia. |
| Q83969762 | Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination |
| Q36883836 | Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease |
| Q74564550 | Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus |
| Q43435083 | Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States). |
| Q82579034 | Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria |
| Q34509469 | Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan |
| Q42261837 | Risk of progression of Barrett's esophagus in patients with cirrhosis |
| Q26155183 | Risk of upper aerodigestive tract cancers in a case-cohort study of autoworkers exposed to metalworking fluids |
| Q40672528 | Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study |
| Q93333040 | Robotic gastrointestinal surgery |
| Q36641320 | Role and new perspectives of transforming growth factor-alpha (TGF-alpha) in adenocarcinoma of the gastro-oesophageal junction |
| Q35917093 | Role of F18-FDG PET/CT in the Staging and Restaging of Esophageal Cancer: A Comparison with CECT. |
| Q35741503 | Role of Rac1 in regulation of NOX5-S function in Barrett's esophageal adenocarcinoma cells |
| Q36450478 | Role of gastrin-peptides in Barrett's and colorectal carcinogenesis |
| Q33626574 | Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells |
| Q33603506 | Role of p53 assessment in management of Barrett's esophagus |
| Q35199175 | Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction |
| Q46042361 | Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer |
| Q91693480 | Salvage cryotherapy in patients undergoing endoscopic eradication therapy for complicated Barrett's esophagus |
| Q37992841 | Second-line chemotherapy for advanced gastric cancer in Korea |
| Q35565680 | Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota |
| Q50223469 | Sentinel node mapping in adenocarcinoma of the esophagogastric junction |
| Q77791053 | Serum levels of 25-hydroxyvitamin D at diagnosis are not associated with overall survival in esophageal adenocarcinoma |
| Q37297394 | Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium |
| Q33618158 | Short segment Barrett's oesophagus: prevalence, diagnosis and associations |
| Q35350847 | Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? |
| Q46560460 | Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential |
| Q35777627 | Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus |
| Q54643270 | Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. |
| Q82897979 | Significance of palisading longitudinal esophagus vessels: identification of the true esophagogastric junction has histopathological and oncological considerations |
| Q43454622 | Significant Racial Disparities Exist in Noncardia Gastric Cancer Outcomes Among Kaiser Permanente's Patient Population |
| Q35586056 | Site distribution of oesophagogastric cancer |
| Q35218771 | Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival |
| Q74402164 | Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia |
| Q74250823 | Small cell carcinoma of the oesophagus |
| Q35000990 | Smoking and Barrett's esophagus in women who undergo upper endoscopy |
| Q35798579 | Somatic mitochondrial mutation in gastric cancer |
| Q74637095 | Specialized intestinal metaplasia and carditis at the gastroesophageal junction in Chinese patients undergoing endoscopy |
| Q31919142 | Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data |
| Q72190661 | Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6-dimethylnitrosomorpholine under the influence of esophagojejunostomy |
| Q51134352 | Squamous cell carcinoma of the esophagus: therapeutic dilemma. |
| Q74610775 | Squamous cell papillomatosis of esophagus following placement of a self-expanding metal stent |
| Q83631394 | Stage-specific therapy for cancer of the oesophagus: a new 'cancer of the elderly' |
| Q37452189 | Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site |
| Q41648500 | Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma |
| Q43196763 | Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats |
| Q57126085 | Surgical Treatment of Gastroesophageal Junction Cancer |
| Q41185303 | Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study. |
| Q48163558 | Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? |
| Q34769005 | Surveillance in Barrett's oesophagus: a personal view |
| Q36193739 | Survival benefit and safety of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy |
| Q78138494 | Survival in stomach cancer is improving: results of a nationwide population-based Swedish study |
| Q35171558 | Survival trends in gastric cancer patients of Northeast China |
| Q24648727 | Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study |
| Q35745029 | Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs |
| Q37672210 | TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett's esophagus: Case series and findings |
| Q37836513 | Targeted therapies for metastatic esophagogastric cancer |
| Q36039645 | Targeted therapy for esophagogastric cancers: a review |
| Q35599748 | Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies |
| Q47562024 | Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? |
| Q34724977 | The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. |
| Q35214843 | The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer |
| Q36108718 | The Role of the Microbiome in Gastrointestinal Cancer. |
| Q46012308 | The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists. |
| Q27851718 | The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells |
| Q37488137 | The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma |
| Q34386199 | The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? |
| Q34755929 | The epidemic of esophageal adenocarcinoma |
| Q40948747 | The epidemiology of functional gastrointestinal disorders in North America |
| Q72097042 | The epidemiology of oesophageal cancer in the UK and other European countries |
| Q42567530 | The expression of c-src gene in the carcinogenesis process of human cardia adenocarcinoma |
| Q35113330 | The feasibility of an exercise intervention in males at risk of oesophageal adenocarcinoma: a randomized controlled trial |
| Q35570968 | The gastric cardia in gastro-oesophageal disease |
| Q73674244 | The gastric cardia: fact or fiction? |
| Q46856948 | The impact of an antireflux procedure on intestinal metaplasia of the cardia |
| Q41601267 | The molecular basis for carcinogenesis in metaplastic columnar-lined esophagus |
| Q36644282 | The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction |
| Q28365932 | The phenotype of gastric mucosa coexisting with Barrett's oesophagus |
| Q35619274 | The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico |
| Q34409501 | The quiet pleasure of browsing through vital statistics |
| Q34678579 | The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. |
| Q35037855 | The role of esophagogastroduodenoscopy in the diagnosis and management of upper gastrointestinal disorders. |
| Q37832427 | The role of radiation in the perioperative treatment of esophagogastric cancer |
| Q97525803 | The safety of esophagojejunostomy via a transorally inserted-anvil method vs extracorporeal anastomosis using a circular stapler during total gastrectomy for Siewert type 2 adenocarcinoma of the esophagogastric junction |
| Q72341899 | The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus |
| Q77833489 | The sinister significance of dysphagia |
| Q37178263 | The value of traditional upper endoscopy as a diagnostic test for Barrett's esophagus |
| Q86033115 | Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction |
| Q33704505 | Time trend and age-period-cohort effects on gastric cancer incidence in Zaragoza and Navarre, Spain. |
| Q68045043 | Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89 |
| Q35585471 | Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland |
| Q30653870 | Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus |
| Q57271548 | Tobacco and alcohol intake in relation to adenocarcinoma of the gastric cardia in Spain |
| Q44667365 | Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia |
| Q36138633 | Total esophagogastrectomy plus extended lymphadenectomy with transverse colon interposition: A treatment for extensive esophagogastric junction cancer |
| Q21093263 | Transhiatal esophagectomy in a high volume institution |
| Q37779057 | Transhiatal versus transthoracic esophagectomy for esophageal cancer |
| Q34295597 | Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis |
| Q35894848 | Transthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis |
| Q24240701 | Treatment for Barrett's oesophagus |
| Q43920736 | Treatment outcomes of resected esophageal cancer |
| Q35178076 | Trend in gastric cancer: 35 years of surgical experience in Japan |
| Q34682076 | Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran |
| Q36291580 | Trends in cancer incidence and mortality in Scotland: description and possible explanations. |
| Q37096847 | Trends in esophageal adenocarcinoma incidence and mortality. |
| Q37255726 | Trends in esophageal cancer and body mass index by race and gender in the state of Michigan. |
| Q36948484 | Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis |
| Q35199193 | Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction |
| Q36013985 | Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status |
| Q34699973 | Undervalued criteria in the evaluation of multimodal trials for upper GI cancers |
| Q35256138 | Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases |
| Q37785235 | Upper Gastrointestinal Cancer Predisposition Syndromes |
| Q34718883 | Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence |
| Q43003832 | Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro |
| Q50513831 | Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. |
| Q35457196 | Utility of endoscopy for diagnosis of barrett in a non-Western society: endoscopic and histopathologic correlation |
| Q85965466 | Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis |
| Q35938492 | Validity of the specialized columnar epithelium as a diagnostic criterion of the short segment Barrett's esophagus |
| Q73227602 | Value of cytology in detecting intestinal metaplasia and associated dysplasia at the gastroesophageal junction |
| Q26998011 | Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence |
| Q43004712 | What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis |
| Q40121148 | Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects |
| Q45288161 | [Recommendations for clinical practice: 2004 Standards, Options and Recommendations for management of patients with adenocarcinomas of the stomach (excluding cardial and other histological forms of cancer) Federation nationale des centres de lutte c |
| Q73285206 | p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia |
Search more.